ឆរ

Gastrointestinal and Hematologic Disorders Flashcards

Myelodysplastic Syndromes

  • Definition: A group of hematopoietic disorders characterized by cellular dysplasia and pancytopenia (↓ RBC, WBC, and platelets).
  • Synonyms: Dysmyelopoietic syndrome, hematopoietic dysplasia, pre-leukemia, refractory anemia.
  • Classifications: Refractory anemia, chronic myelomonocytic leukemia, refractory anemia with excess blasts in transformation.

Epidemiology

  • Predominant Age: Elderly, >65 years.
  • Children: Uncommon.
  • Progression: May progress to acute myeloid leukemia (AML).
  • Predominant Sex: Male = Female.
  • Incidence: 1-2/100,000 per year.

Risk Factors

  • Exposure to benzene and gasoline.
  • Smoking.
  • Treatment with alkylating agents or radiotherapy.
  • Genetic factors: G6PD mutation, RAS oncogene mutation.
  • Clonal neoplasms by cytogenetic abnormalities.
  • Unknown etiology.

Pathophysiology

  • Clonal hematopoiesis leading to expansion of abnormal clones and apoptosis.
  • Genetic mutations leading to increased apoptosis in the early stages.
  • Ineffective hematopoiesis causing anemia, neutropenia, and thrombocytopenia.

Signs & Symptoms

  • Anemia: Fatigue, pale skin, shortness of breath, lightheadedness, angina.
  • Leukopenia: Fever, increased risk of infection.
  • Thrombocytopenia: Easy bruising, petechiae, epistaxis, purpura.
  • **Skin infiltrates.
  • Splenomegaly: Uncommon, but may occur in chronic myelomonocytic leukemia (CMML).

Diagnosis

  • Cytogenetic tests for clonal chromosomal abnormalities.
  • Rule out other causes: nutritional deficiencies, toxic exposures, autoimmune disorders.
  • Granulocyte function test.
  • Platelet function test.
  • Marrow colony assays.
  • Immunophenotyping.

Laboratory Findings

  • Increased MCV (macrocytic anemia).
  • Reticulocyte count (may be elevated or normal).
  • Bone marrow failure.
  • Anemia: Macrocytic (MCV > 100), poikilocytosis, anisocytosis, reticulocytosis.
  • Granulocytopenia: Hypogranular or agranular neutrophils.
  • Thrombocytopenia: Giant platelets or hypogranular platelets.
  • HbF (fetal hemoglobin): Should be ruled out as a cause; Thalassemia; HbF fetus stage.
  • Coombs test: To rule out hemolytic anemia.
  • Imaging: Liver/spleen scan for splenomegaly or lymphadenopathy.
  • Bone marrow aspiration, biopsy: Hypercellular with increased blasts.
  • Peripheral blood smear.

Differential Diagnosis

  • Myeloproliferative disorders (no cytopenia).
  • AML or erythroleukemia (acute).
  • Chronic myeloproliferative disorders (adequate maturation).
  • Polycythemia Vera (too much blood production, Hb 17-18).
  • Myeloid metaplasia with myelofibrosis.
  • Malignant lymphoma.
  • Metastatic carcinoma.

Treatment

  • Immunizations: Pneumococcal pneumonia, influenza, Hep B.
  • RBC transfusions.
  • Platelet transfusions.
  • Early antibiotic use.
  • Diet: Avoid alcohol and iron intake.
  • Medications:
    • 1st line: Azacytidine, Decitabine, Lenalidomide.
    • Chemotherapy.
    • Bone marrow transplant.
    • 2nd line: Low dose cytarabine, interferon, cyclosporine, granulocyte colony-stimulating factor.

Prognosis

  • Refractory anemia (survival: 5 years or longer).
  • Others: 1 year (death due to AML or infection/bleeding).

Complications

  • Infection.
  • Bleeding.
  • Complications of anemia and transfusion.
  • Citrate toxicity -> Urolithiasis (from citrate in blood bags).

Acute Myeloid Leukemia (AML)

  • Synonyms: Acute myelogenous leukemia, acute granulocytic leukemia.
  • Definition: Cancer of the blood and bone marrow affecting myeloid cells (↓ RBC, WBC, platelets) with rapid growth of abnormal WBCs.

Epidemiology

  • Adults > 45 years.
  • 1% of all cancer types.

Risk Factors

  • Age (more common in older adults).
  • Sex: Male > Female.
  • Smoking (leads to lung cancer).
  • Exposure to chemicals: Benzene, oil refinery, shoe manufacturing, gasoline.
  • Exposure to formaldehyde.
  • Chemotherapy drugs: Alkylating drugs (Cyclophosphamide, Procarbazine, Busulfan).
  • High dose radiation exposure.
  • MDS.
  • Genetic: Fanconi anemia, Bloom syndrome, Neurofibromatosis type I.
  • Family history.

Etiology

  • Abnormality of chromosome aging.
  • Genetic mutations.
  • Changes in DNA affecting control functions.
  • Decrease in tumor suppressor genes.

Diagnosis

  • Screening tests for early detection are not helpful in AML.
  • Blasts in AML.

Signs & Symptoms

  • Non-specific: Weight loss, fatigue, fever, night sweats, loss of appetite.
  • Leukopenia: Fever, infection.
  • Thrombocytopenia: Bruises, excess bleeding, nosebleed, bleed gums, heavy periods.
  • Confusion.
  • Splenomegaly.
  • Hepatomegaly.
  • Bone marrow infiltration.
  • Enlarged lymph nodes.
  • Swelling, pain, bleeding gums.

Subtypes

  • Goal: for easier treatment
  • M0-M5: Immature forms of WBC- monocyte
  • M6: Very immature forms of RBC- erythroblast
  • M7: Immature forms of platelet making.

Prognosis

  • Depends on factors, subtypes.

Treatment

  • Refers to Oncology department.
  • Chemotherapy.
  • Radiotherapy.

Differential Diagnosis MDS vs AML

  • Blasts <20% vs Blasts ≥20%.

Chronic Myeloid Leukemia (CML)

  • Definition: Cancer of WBCs characterized by increased unregulated growth of myeloid cells in bone marrow and accumulation in blood.
  • Chronic > 3 months without proper treatment.
  • Differentiate of MDS, AML, CML.

Epidemiology

  • Male > Female.
  • Age: Any age, mostly 60 years.
  • Adults (mainly), children (rarely).

Risk Factors

  • Expose skin to strong sunlight.
  • Smoking.
  • High dose radiation exposure (atomic bomb or nuclear).
  • Aging.
  • Sex: Male > female.
  • G6PD deficiency.

Etiology

  • Chromosome 9 and 22 swapped (Philadelphia chromosome).
  • Defected chromosome (oncogene): BCR-ABL gene.
  • Produce protein cause CML grow & divide out of control.

Signs & Symptoms

  • Weakness.
  • Fatigue.
  • Night sweats.
  • Weight loss.
  • Fever.
  • Risk of infection.
  • Bone pain, joint pain (caused by leukemia spreading from marrow cavity to bone or joint).

Diagnosis

  • Screening CBC: abnormity of RBC, WBC, platelets.
  • Tumor marker (should be next if CBC level is normal/abnormal).
  • Lab test: Increased WBC, immature myeloblasts, increased platelets.
  • Bone marrow biopsy: Hypercellularity with myeloid hyperplasia.
  • Philadelphia chromosome presence.

Phases of CML

  • Chronic phase: Blasts <10%; more responsive to tyrosine kinase inhibitors.
  • Accelerated phase: Basophilia, blasts 15%; not respond well to treatment.
  • Blast phase: Large cluster of blast in bone marrow, Blasts ≥20%; like AML symptoms, refractory.

Prognosis

  • Depends on CML phases.

Liver Cirrhosis

  • Definition: Chronic liver disease leading to inflammation, necrosis, fibrosis, and stellate activation - end result liver failure or cancer
  • Definition Chronic liver disease (alcohol abuse)Chronic Liver disease (non-alcohol +obesity) -> liver steatosis (fatty liver disease) -> fat + liver secrete enzyme irritate hepatocyte -> prolong -> liver steatosis.

Epidemiology

  • Predominant age: 40-50 /peak incidence
  • Predominant sex: Male
  • Alcohol abuse -15th cause of death at 45-54 yrs
  • 12 cause of death in US adults

Genetics:

  • hemochromatosis
  • wilson disease
  • a1-Antitrypsin deficiency in adults

Etiology & Pathophysiology

  • Toxins -> hepatocyte injury -> secrete paracine factor to become -> activate & change stellate -> transforming growth factor-B-1
  • Virus -> stellated -> lose vit. A & start secrete TGF-B1
  • Produce collagen - extracellular matrix -> fibrosis & scaring compress central vein & sinusoid but normally healthy liver state stellated function wound healing on liver injury cirrhosisbile stasis (gallstone, duct obstruct bile reflux into liver-
  • Metabolic disorder (PTG + poor liver inflammation -> liver steatosis)
  • Autoimmune disease

Risk Factors

  • Alcohol abuse
  • History of viral hepatitis
  • Family history of primary liver cancer
  • Signs & Symptoms
  • Asymptomatic early stage (liver compensate I still get - work done)
  • Non-specific : weight loss , weakness, fatigue, anorexia
  • Late stage (liver decompensate) -> extensive fibrosis (malfunction

Clinical Manifestations of decompensated liver state

  • Skin changes spider angiomata - superficial vein
  • Xanthoma(cholesterolmotiveheimer liver malfunction
  • hyperpigmentation
  • jaundice
  • Caput medusa Overflow of fluid in belly (joy belly & umbilical cord vory/o)
  • Leg edema
  • Hepatomegaly, splenomegaly , cirrhotic liver